Literature DB >> 13407710

Stimulation of non-specific immunity by the lipid A component of bacterial lipopolysaccharide.

J G HOWARD, D ROWLEY, A C WARDLAW.   

Abstract

Entities:  

Keywords:  IMMUNITY; LIPIDS/effects

Mesh：

Substances：

Year:  1957        PMID： 13407710     DOI： 10.1038/179314a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  [Methodical and clinical research on the properdin system. I. Methodical research on the simplified properdin test according to Isliker].

Authors:  G SCHUMACHER; F KNIERIM; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

2.  The effect of Mycobacterium tuberculosis (BCG) infection on the resistance of mice to bacterial endotoxin and Salmonella enteritidis infection.

Authors:  J G HOWARD; G BIOZZI; B N HALPERN; C STIFFEL; D MOUTON
Journal:  Br J Exp Pathol       Date:  1959-06

3.  [Mechanisms of nonspecific infection resistance].

Authors:  D BOHME
Journal:  Klin Wochenschr       Date:  1958-09-15

4.  Investigations on the mechanism of stimulation of non-specific immunity by bacterial lipopolysaccharides.

Authors:  J G HOWARD; D ROWLEY; A C WARDLAW
Journal:  Immunology       Date:  1958-07       Impact factor: 7.397

5.  [Effect of lipid and polysaccharide components of endotoxic lipopolysaccharides of gram-negative bacteria on leukocyte culture].

Authors:  G SCHMIDT; E EICHENBERGER; O WESTPHAL
Journal:  Experientia       Date:  1958-08-15

Review 6.  Molecular aspects of endotoxic reactions.

Authors:  A Nowotny
Journal:  Bacteriol Rev       Date:  1969-03

7.  The effect of bacterial constituents on the resistance of mice to heterologous infection and on the activity of their reticulo-endothelial system.

Authors:  D BOEHME; R J DUBOS
Journal:  J Exp Med       Date:  1958-04-01       Impact factor: 14.307

8.  Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Lorenzo Galluzzi; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.